TRDA Long Put Strategy

TRDA (Entrada Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.

TRDA (Entrada Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $300.5M, a beta of -0.26 versus the broader market, a 52-week range of 4.93-16.45, average daily share volume of 369K, a public-listing history dating back to 2021, approximately 183 full-time employees. These structural characteristics shape how TRDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -0.26 indicates TRDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long put on TRDA?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current TRDA snapshot

As of June 29, 2026, spot at $7.67, ATM IV 260.60%, IV rank 51.38%, expected move 74.71%. The long put on TRDA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long put structure on TRDA specifically: TRDA IV at 260.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 74.71% (roughly $5.73 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TRDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TRDA should anchor to the underlying notional of $7.67 per share and to the trader's directional view on TRDA stock.

TRDA long put setup

The TRDA long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TRDA near $7.67, the first option leg uses a $7.67 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TRDA chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TRDA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$7.67N/A

TRDA long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

TRDA long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on TRDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on TRDA

Long puts on TRDA hedge an existing long TRDA stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying TRDA exposure being hedged.

TRDA thesis for this long put

The market-implied 1-standard-deviation range for TRDA extends from approximately $1.94 on the downside to $13.40 on the upside. A TRDA long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long TRDA position with one put per 100 shares held. Current TRDA IV rank near 51.38% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on TRDA should anchor more to the directional view and the expected-move geometry. As a Healthcare name, TRDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TRDA-specific events.

TRDA long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TRDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TRDA alongside the broader basket even when TRDA-specific fundamentals are unchanged. Long-premium structures like a long put on TRDA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current TRDA chain quotes before placing a trade.

Frequently asked questions

What is a long put on TRDA?
A long put on TRDA is the long put strategy applied to TRDA (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With TRDA stock trading near $7.67, the strikes shown on this page are snapped to the nearest listed TRDA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are TRDA long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the TRDA long put priced from the end-of-day chain at a 30-day expiry (ATM IV 260.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a TRDA long put?
The breakeven for the TRDA long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TRDA market-implied 1-standard-deviation expected move is approximately 74.71%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on TRDA?
Long puts on TRDA hedge an existing long TRDA stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying TRDA exposure being hedged.
How does current TRDA implied volatility affect this long put?
TRDA ATM IV is at 260.60% with IV rank near 51.38%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related TRDA analysis